Mach7 Technologies (M7T) investor relations material

Strategic reset and financial transformation

• Achieved positive operating cash flow in Q2 and Q3, maintaining zero debt and a strong balance sheet.

• Cost base reduced by 6% through disciplined management and operational overhaul.

• Shifted focus from lumpy capital deals to a recurring revenue model, strengthening financial predictability.

• Leadership team revitalized, emphasizing cost discipline and commercial execution.

• Growth now prioritized following a reset year focused on internal restructuring.

Market opportunity and industry trends

• Enterprise imaging market projected to double by 2030, reaching AUD 4 billion.

• Increasing demand for AI-enabled imaging and digital pathology due to radiologist shortages and rising imaging volumes.

• Open APIs, EMR interoperability, and hybrid cloud/on-prem solutions are key industry trends.

• Security and compliance are critical, with healthcare organizations facing heightened cyber threats.

• Modular solutions allow customers to modernize without high-risk system replacements.

Product innovation and differentiation

• Vendor-neutral archive (VNA) ingests images from any source, supporting true data independence.

• eUnity Enterprise Diagnostic Viewer offers zero-footprint, FDA-approved access to diverse image types.

• Flamingo Architecture enables modular upgrades, validated with early adopter customers and expanding in FY27.

• Differentiators include data independence, security, price-to-performance value, and customer-centric innovation.

• Customer engagement drives product development, with direct developer-customer collaboration.